Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.

Rubino, Domenica; Abrahamsson, Niclas; Davies, Melanie; Hesse, Dan; Greenway, Frank L; Jensen, Camilla; Lingvay, Ildiko; Mosenzon, Ofri; Rosenstock, Julio; Rubio, Miguel A; Rudofsky, Gottfried; Tadayon, Sayeh; Wadden, Thomas A; Dicker, Dror

Rubino, Domenica; Abrahamsson, Niclas; Davies, Melanie; Hesse, Dan; Greenway, Frank L; Jensen, Camilla; Lingvay, Ildiko; Mosenzon, Ofri; Rosenstock, Julio; Rubio, Miguel A; Rudofsky, Gottfried; Tadayon, Sayeh; Wadden, Thomas A; Dicker, Dror.

Affiliation

Rubino D; Washington Center for Weight Management, Arlington, Virginia.
Abrahamsson N; Endocrinology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Davies M; Diabetes Research Centre, University of Leicester, Leicester, England.
Hesse D; NIHR Leicester Biomedical Research Centre, Leicester General Hospital, Leicester, England.
Greenway FL; Novo Nordisk A/S, Søborg, Denmark.
Jensen C; Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge.
Lingvay I; Novo Nordisk A/S, Søborg, Denmark.
Mosenzon O; Departments of Internal Medicine/Endocrinology and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas.
Rosenstock J; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Rubio MA; Dallas Diabetes Research Center at Medical City, Dallas, Texas.
Rudofsky G; Department of Endocrinology and Nutrition, Hospital Clínico Universitario San Carlos and Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Faculty of Medicine, Universidad Complutense, Madrid, Spain.
Tadayon S; Department of Endocrinology and Metabolic Diseases, Kantonsspital Olten, Olten, Switzerland.
Wadden TA; Novo Nordisk A/S, Søborg, Denmark.
Dicker D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

JAMA ; 325(14): 1414-1425, 2021 04 13.

Article de En | MEDLINE | ID: mdl-33755728

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Perte de poids / Peptides glucagon-like / Surpoids / Glucagon-like peptide 1 / Obésité Type d'étude: Clinical_trials / Prognostic_studies Limites: Adult / Female / Humans / Male / Middle aged Langue: En Journal: JAMA Année: 2021 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google